Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Replimune Group Appoints Michelle Di Napoli As Chief Commercial Officer
PUBLIC · REPLAug 23, 2026•about 3 hours ago
Position
Chief Commercial Officer
Company
Replimune
Michelle DiNapoli
WoburnBiotechnologyHealth Care
Description
Replimune Group has appointed Michelle DiNapoli as Chief Commercial Officer, following the release of their first-quarter 2026 results. This leadership change comes amidst a reduced net loss and new financing options aimed at reshaping the company's investment narrative.
Company Information
Company
Replimune
Location
Woburn, Massachusetts, United States
About
Replimune is working to advance the science of oncolytic immunotherapy to improve on existing therapies and help treat more patients with a variety of tumor types. Oncolytic immunotherapy uses viruses that have been modified to selectively replicate in and kill tumors.
Replimunes' goal is to develop powerful therapies to overcome cancer.
Don't miss Replimune's next move
Get an email the moment Replimune changes its leadership, hires an exec, or expands, usually minutes after it happens.